Fractionalized BD
Revenue Infrastructure System
“Our Revenue Infrastructure System is always on. It compounds while you sleep, educates while you’re silent, and builds your pipeline even when you’re not selling.”
Life Science Sales Challenges
Stop Hoping Conferences and Introductions Will Scale Your Business.
Life Science Company’s Sales Challenges
- Pipeline Instability & Long Sales Cycle
- Over Reliance on Limited Networks
- Ineffective Differentiation
- Misaligned Marketing & Business Development
- Global Complexity & Compliance Barriers
- Underinvestment in Sales Infrastructure
Our System Builds Consistent Sales Pipelines
Fractionalized BD is not outsourcing, not freelance activity and not more promotions.
Fractionalized BD is a Revenue Infrastructure System Built to Transform Life Science Companies’ Pipelines From Unpredictable to Consistent Because it:
- Assesses Client Collateral Materials – Any Newsletters, Webinars, Case Studies, White Papers etc.
- Creates Demand Through Profiling KOL Expertise
- Educates the Market Early
- Attracts Qualified Accounts
- Shortens Sales Cycles
- Increases Deal Readiness
- Always Stays ON and Compounds Your Newsletters and Webinars – It Works Even When You Don’t
Why Life Science Companies Need This System
- Modern Buyers Complete Almost 80% of Their Evaluation Before Vendor Contact – Gartner (2020, “The New B2B Buying Journey”) and 6sense (2025 “Unmatched Visibility into the Buyer’s Journey”)
- Companies Must Leverage Newsletters to Pull Readers Your Website and Collateral Materials and Use Webinars to Educate Your Target Audience to Build Trust
- Conference Only Introductions are Unpredictable and Expensive
- Founder Dependency Collapses Scaling
Activate Your "90 Day Ignite" System
- Install Revenue Infrastructure in 90 Days.
- Not a Pilot. Not a Trial.
- Install. Execute. Measure.
About BioAlliance Strategies
Founded in 2011, BioAlliance Strategies solves a persistent problem in life sciences growth. There was a definite need to build a revenue infrastructure system for smaller companies where high-dollar sales teams aren’t possible.
We exist to help CROs, biotech, pharma, and clinical sites translate expertise into predictable pipeline, credibility, and long-term enterprise value. BioAlliance was built around one principle: growth must be systematic, measurable, and board defensible. We combine strategic corporate and business development, plus compliant global marketing to install repeatable revenue systems, not disconnected activities. Our mission is to help life science companies scale.
Historical Metrics
40k+
Industry Contacts
95%
Newsletter Delivery Rates
4k+
Newsletter Opens / Month
200+
Successful Client Webinars
Fractionalized BD & Case Studies
Our Clients
We Serve the Life Sciences for Contract Research Organizations (CROs), Biotech, Pharma, Medtech, Diagnostics, and Digital Health
Graeme Ladds - Founder & CEO, PharSafer
Hillary Veeder - Principal, Cobble Consulting
Denise McNerney & Chris Matheus | GLSA Executive Team
The Proven Leader of Fractionalized Business Development Strategies to The Life Science Industry
Contact
Our Services
Subscribe to get notifications about new updates.
